Co-Authors
This is a "connection" page, showing publications co-authored by Patrick Mauldin and Kit Simpson.
Connection Strength
0.743
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.147
-
The one-year attributable cost of post-stroke dysphagia. Dysphagia. 2014 Oct; 29(5):545-52.
Score: 0.121
-
The one-year attributable cost of poststroke aphasia. Stroke. 2012 May; 43(5):1429-31.
Score: 0.103
-
Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
Score: 0.079
-
Charges for hospital admissions attributable to health disparities for African-American patients, 1998-2002. J Natl Med Assoc. 2006 May; 98(5):690-4.
Score: 0.069
-
High-risk opioid analgesic dispensing to adolescents 12-18?years old in South Carolina: 2010-2017. Pharmacoepidemiol Drug Saf. 2022 03; 31(3):353-360.
Score: 0.051
-
High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018. J Public Health Manag Pract. 2021 Jul-Aug 01; 27(4):379-384.
Score: 0.049
-
Trends in Dispensed Opioid Analgesic Prescriptions to Children in South Carolina: 2010-2017. Pediatrics. 2021 03; 147(3).
Score: 0.048
-
Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636.
Score: 0.048
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.030